Assure Holdings Corp. (NasdaqCM:IONM) acquired Substantially All of the Assets of Neuroprotect Neuromonitoring, LLC for $0.40665 million on December 30, 2022. The Assets were acquired at Closing for a purchase price of 1,500,000 shares of common stock of the Company. The common stock is subject to regulatory and securities law restrictions. Jason K. Brenkert of Dorsey & Whitney LLP acted as legal advisor to Assure. ROTH Capital Partners, LLC acted as financial advisor to Assure. The Company agreed to pay Roth for its services by issuing to it a warrant to purchase 180,000 shares of the Company's common stock at a strike price per share of USD $1.40 for a term of five years.

Assure Holdings Corp. (NasdaqCM:IONM) completed the acquisition of Substantially All of the Assets of Neuroprotect Neuromonitoring, LLC for $0.24 million on December 30, 2022. As of March 31, 2023 as consideration, Assure issued to NervePro 75,000 shares of common stock of the Company at a deemed price of $5.20 per share based on closing price on December 30, 2022.